• 1st Mantle Cell Lymphoma Patient Dosed in Phase 1/2 Trial Testing Cirmtuzumab-Imbruvica Combo
  • ‘Social Network’ of Genes May Help Identify New Therapy Targets for Lymphoma, Other Cancers
  • Young Cancer Survivors Show Signs of Accelerated Aging, Study Finds
  • Zevalin Plus Aggressive Chemotherapy Safe, Effective for Follicular Lymphoma, Phase 2 Trial Shows
  • Bowel Rest Not Seen to Benefit NHL Patients with Gastrointestinal Involvement in Study
  • UK Agency Recommends 3 New Blood Cancer Therapies, Including Adcetris for Lymphoma
  • I’ve Seen the Impact of Cancer Research
  • Gift of Life Marrow Registry Helps California Dad with Leukemia
  • Forty Seven’s 5F9 Immunotherapy on FDA Fast Track for DLBCL, Follicular Lymphoma
  • Arthritis Medication May Prevent GvHD, Side Effect of Stem Cell Transplants, Mouse Study Suggests
  • Takeda, Nectar Plan to Test New IO Combination in non-Hodgkin Lymphoma Patients
  • FDA Approves Kymriah for Relapsed or Refractory Large B-cell Lymphoma